Skip to main content

Table 2 Contact prophylaxis offered to household contacts of children with iGAS disease notified to the PAEDS Network, Australia, 1 July 2016–30 June 2018

From: Invasive group A Streptococcus disease in Australian children: 2016 to 2018 – a descriptive cohort study

 

Total patients (N)

Patients with contact prophylaxis offered (n)

Proportion of total patients with contact prophylaxis offered (%)a

Risk ratio of offering contact prophylaxis (RR, 95% CI)b

Total

181

85

47.0

Gender

 Female

74

36

48.6

Ref

 Male

107

49

45.8

0.94 (0.69–1.29)

Hospital

 RCH

37

30

81.1

Ref

 MCH

24

14

58.3

0.72 (0.50–1.04)

 QCH

43

2

4.7

0.06 (0.01–0.22)

 WCH

22

15

68.2

0.84 (0.61–1.16)

 RDH

5

0

0.0

Not calculable

 PCH

27

20

74.1

0.91 (0.70–1.20)

 CHW

23

4

17.4

0.21 (0.09–0.53)

Disease severity

 Not severe

107

48

44.9

Ref

 Severe

74

37

50.0

1.11 (0.82–1.52)

Age group

 < 1 year

32

16

50.0

0.99 (0.66–1.48)

 1–4 years

83

42

50.6

Ref

 5–9 years

42

19

45.2

0.89 (0.60–1.33)

 10–14 years

21

6

28.6

0.56 (0.28–1.15)

 15–17 years

3

2

66.7

1.32 (0.57–3.02)

Indigenous Australian ethnicity

 Yes

21

8

38.1

0.79 (0.45–1.40)

 No/Don’t know

160

77

48.1

Ref

Patient with a household contacts aged < 10 years

 Yes

116

69

59.5

2.42 (1.54–3.79)

 No/Don’t know

65

16

24.6

Ref

Severe disease

 Yes

74

37

50.0

1.11 (0.82–1.52)

 No

107

48

44.9

Ref

  1. aDue to rounding, some totals will add to >100.0%
  2. bBold type indicates result is statistically significant
  3. RCH Royal Children’s Hospital Melbourne, Victoria; MCH Monash Children’s Hospital, Victoria; QCH Queensland Children’s Hospital, Queensland; WCH Women’s and Children’s Hospital, South Australia; RDH Royal Darwin Hospital, Northern Territory; PCH Perth Children’s Hospital, Western Australia; CHW Children’s Hospital at Westmead, New South Wales